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Sažetak:
Mjerenje funkcije jetre nakon embolizacije temelji se na primjeni specificˇnog
kontrasta za jetru, koji se putem jetre izlucˇuje u žucˇ te snimanjem cijelog procesa
magnetskom rezonancom. Zatvaranjem jednog kraka portalne vene koja omoguc´uje
dovod hranjivih sastojaka, poticˇe se rast drugog dijela jetre koji na sebe preuz-
ima funkciju djela zaraženog tumorom. Analiza snimaka magnetske rezonance,
koja se sastoji od nekoliko faza, daje krivulje koje predstavljaju vremensku
promjenu koncentracije kontrasta u krvi i tkivu jetre. Primjenom farmakokineticˇkih
modela za opisivanje krivulja dobivamo parametre koji opisuju funkciju jetre;
perfuziju, brzinu apsorpcije te izlucˇivanja kontrasta, volumen hepatocita te si-
nusoidalnih stanica.
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Abstract:
Measurement of liver function after embolization is based on the application of
specific liver contrast agent which can be excreted through liver into the bile and
recording the whole process with magnetic resonance. By closing the branch of
the portal vein which enables food supply, we stimulate the growth of the sec-
ond, healthy, part of the liver. The analysis of MRI recordings consists of several
phases and gives curves that represent time-varying contrast concentrations in
blood and liver tissue. By using pharmacokinetic models for fitting the curves
we obtain parameters that describe the function of the liver; perfusion, contrast
uptake and extraction rate, volume of hepatocytes and sinusoidal cells.
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1 Introduction
Portal vein embolization is medical procedure used before hepatic resection.
Before hepatectomy, functional liver remaining has to reach the sufficient size
necessary for liver regeneration after surgery. Preoperative embolization of the
portal vein which feed the hepatic segments reduced the risk of postoperative
liver failure after liver resection. The aim of embolization is complete obstruc-
tion of the targeted branches and redistribution of flow to the future liver remain.
Radiologist places a needle into the liver and when he identify blood vessels, in-
ject small microspheres into the vessel to block blood supply. The size of the
particles is 300µm to 900µm. The procedure is frequently used in primary liver
cancer or colorectal liver metastases (Romaric Loffroy 2015).
Global assessment of liver function is assessed by laboratory tests such as ICG
(indocyanine green) test or LiMAx (maximum liver function capacity) test. Post-
operative liver residue is examined by volume using CT or MRI because tests are
limited when liver function is not homogeneously distributed. One of techniques
for image-based liver function estimation is dynamic contrast-enhanced MRI.
Distribution of contrast agent can be easily displayed by magnetic resonance
imaging (MRI) with high temporal and spatial resolution (D. Geisel 2015).
In this master thesis it will be explained principle of magnetic resonance and
origin of the MR images. I will describe blood supply in the liver because it is
crucial for understanding of contrast agent flow. In section about methods are
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shown data processing steps of the recordings. The aim of the work is investigate
pharmacokinetic models which can best describe uptake, pathway and excretion
of liver specific contrast agent, so in contiuation are shown fitting procedure,
models and the results processed by individual models.
2
2 Theoretical background
2.1 Basic principles
The most abundant atom in human body is hydrogen because it is one of the
component of water and fat. Hydrogen consist of electron which orbit a positive
nucleus. Electron and nucleus are also spinning around their own axis. Since
the nucleus contains positively charged proton, due to nuclei spin, nuclei can
be consider as a small magnet because of electromagnetic induction. Magnetic
moment of each nuclei can be described with vector which represents the direc-
tion and size of magnetic moment. When these magnetic active nuclei are not in
the presence of magnetic field their orientations are random, but when we apply
some external magnetic field B0 they tend to align with the field. Depending on
their energy, magnetic moment of the nuclei will align parallel or anti-parallel
(Figure 2.1).
The influence of external magnetic field causes the precession of the magnetic
moments around B0. Precessional frequency ω0 or so called Larmor frequency
depends on external magnetic field B0 and gyromagnetic ratio γ:
ω0 = B0 ∗ γ· (2.1)
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Figure 2.1: Orientation of nuclei magnetic moments. Nuclei with higher energies will align
anti-parallel, while nuclei with lower energy states will align parallel to B0. (The
University of Meine)
Figure 2.2: Precession of magnetic moments with frequency ω (The University of Meine)
.
The nucleus can gain energy only if it is equal to energy of precession of the
spin. Energy of hydrogen corresponds to the radio frequency from 106Hz to
109Hz, so the application of a radio frequency (RF) pulse will cause excita-
tion. Excitation results in more nuclei in a higher energy state. Resonance also
causes magnetic momentum vectors to no longer lie parallel to B0. The angle
4
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to which vector shifts out of alignment is called flip angle and depends on the
RF pulse. The other result of resonance is coherence; the vectors are moving
in phase and generate the MR signal when cutting across the coil. That process
induces electric signal. Therefore, signal intensity is proportional to the amount
of magnetization present in transverse plane.
After RF pulse, magnetic vectors lose coherency and recover their longitudi-
nal magnetization. T1 recovery is caused by nuclei giving up their energies to
the surrounding lattice. It is exponential process in which T1 relaxation time
represent the time it takes 63% of the longitudinal magnetization to recover in
the tissue. T2 decay represents the loss of coherent transverse magnetization
which can also be described with exponential function. T2 relaxation time is
point when the 63% of transverse magnetization is lost (Catherine Westbrook
2011).
2.2 Pulse sequence
Dephasing is not caused only by nuclei losing energy, but also with inhomo-
geneities in tissue. Inhomogeneities are areas which do not match the external
magnetic field and that affects the Lamour frequency. Inhomogeneity produce
rapid loss of coherent transverse magnetization and signal. To measure relax-
ation the signal has to be recovered and there are two ways for doing this - using
a 180◦ RF pulse or using gradients.
The spin echo pulse sequence uses 90◦ excitation pulse to flip the magnetic vec-
tor in the transverse plane. Right after the 90◦ RF pulse, T1 recovery and dephas-
ing starts. To compensate dephasing, a 180◦ RF pulse is applied. The 180◦ RF
flips individual magnetic moments for 180 degrees so that the leading (’fastest’)
5
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vector becomes the trailing (’slowest’) vector while the direction of precession
remains the same. This transverse magnetization induces signal in the coil and
it is called spin echo.
The gradient echo pulse sequence uses an RF excitation pulse and flips the mag-
netic vectors through any angle, mostly less then 90◦. That means that the trans-
verse component of magnetization is smaller then in spin echo because only one
part of longitudinal vectors are completely flipped to transverse plane. After the
RF pulse, relaxing signals are produced. The magnetic moments in transverse
plane starts dephasing, but instead of 180◦ RF pulse, vectors are rephased by
gradient. The gradient causes changes in magnetic field strength and produces
coherence. This signal is called a gradient echo (Catherine Westbrook 2011).
Figure 2.3: A basic rephasing sequence (Catherine Westbrook 2011)
2.2.1 Gradient echo pulse sequence
Magnetic field gradients are generated by coils situated within the bore of the
magnet. Through every coil passes electric charge and induces magnetic field
which interacts with the main magnetic field. Whether a gradient field increases
or decreases, main magnetic field depends on the direction of current passing
through gradient coils. Gradient can be activated in 3 directions; x,y and z axes.
6
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The magnetic isocentre is the point of 3 axes where precession frequency re-
mains unchanged. In the main magnetic filed all nuclei has the same Larmor
frequency, because they experience the same magnetic field. When they experi-
ence gradient magnetic filed their precession frequency is changed and they lose
a coherence. If gradient is applied to incoherent vectors it can increase the pre-
cession frequency of the ’slower’ vectors, and decrease the precession frequency
of ’faster’ ones. Gradient magnetic field can be subtracted from B0 or added to
B0 and form steep or shallow slopes. Gradient can be used for more purposes;
besides dephasing and rephasing in pulse sequence they preform slice selection,
frequency encoding and phase encoding.
Gradient echo enables faster imagining. T*2 decay is caused by static dephasing
effects, which occur because of susceptibility of tissues (T’2 decay), and time
variant field fluctuations between magnetic moments of neighboring spins (T2
decay). Spin echo imagining can nullified T’2 dephasing effects because 180◦
RF pulse which corrects static field imperfections. Those imperfections can not
be refocused with gradient echo so that T*2 includes T2 and T’2 effects and
the signal will decay much faster (Michale Markl 2012). TR is time between
two excitation pulse and together with flip angle controls T1 relaxation. TE is
time between excitation and signal and it effects on T2* decay. If we want to
get T1 weighting image we have to maximize the difference in T1 times of the
tissues. To obtain T2 weighting image we have to maximize T2* differences i.e.
TE should be long enough so vectors can decay and show the differences. Flip
angles and TR should be short. To get proton density weighting T1 and T2*
processes are minimized so that we use short TE and long TR because we do
not want recovery of magnetization. (Catherine Westbrook 2011)
7
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2.2.2 FLASH imagining
Magnetic resonance measuring with long measuring times result with motion
artifacts and they can not give us information about fast physiological pro-
cesses. There are few rapid techniques of imagining, but they have low signal
to noise ration (SNR) or require large number of RF pulses. Fast low angle shot
(FLASH) imaging has optimal SNR, reduced measuring time and good spatial
resolution. Main difference between other MRI techniques and FLASH is the
use of RF pulses with low flip angles which eliminate waiting periods between
excitation. Instead of excitation entire longitudinal magnetization FLASH tech-
nique excite only small part of it. With every pulse available longitudinal mag-
netization is separated into transverse part and remaining longitudinal part. TR
and TE can be as much short as hardware of gradient system allows it. TE is
time between RF pulse and highest peak of signal. Imaging time depends on
number of desired projection, duration of slice selection and acquisition of data
(A.Haase 1986).
During FLASH imaging RF pulses are applied together with gradient which
affect only certain slices of object in one direction (G-slice). Spatial discrim-
ination in second direction comes from presence from perpendicular gradient
which cause the free induction decay (FID) (G-read) and creates gradient echo
signal. Phase-encoding gradient (G-phase) preforms spatial encoding in the sec-
ond dimension what we can see on Figure 2.4. (David Stark 1999).
2.2.3 Keyhole filling
K space is spatial frequency domain in which we can store the frequency signals
from MRI. It has 2 axes; phase axis is vertical and the frequency axis is hori-
8
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G-Slice
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G-Read
Figure 2.4: FLASH imaging
zontal (Figure 2.5. For every phase one line in K space is filled. Fast Fourier
transformation enables obtaining of MRI images from data in K space. The
sampled data correspond to Nx × Ny matrix, where Nx represents the number
of frequency data points and the Ny represent the number or TR times.
The reduced k-space filling, also known as keyhole imaging, represents tech-
nique for shortening the acquisition time of the MR data. This technique mini-
mizes the number of TR steps by replacing the missing data points in K-space.
The low spatial frequencies with high amplitudes and low phase shifts in the
central region determine the coarse structure. The high spatial frequencies in
the outer region give us the detailed information. (Zahif 2014)
With TWIST technique it is possible to achieve improvements in temporal and
spatial resolution in shorter time relative to other dynamic imaging. To shorten
9
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kz
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B
Figure 2.5: K space
time TWIST sequence use short TR, reduce spatial resolution, partial Fourier,
apply rectangular field of view and use parallel imaging. To increase the tempo-
ral resolution we can manipulate with the amount of data during acquisition. It is
not necessary to cover the whole K space during converting signals. K space can
be divided into two sections; A region which includes low frequency and carry
the information about contrast and B region which includes high frequency re-
sponsible for image details. Since temporal resolution depends on total number
of K space multiplied by TR, to improve it, we have to reduced the number of
data from region B. (Gerhard Laub 2006)
2.3 Liver physiology
Liver is the largest organ in human body. It is divided into right and left lobe
by falciform ligament and contains eight sections. On the inferior liver surface
next to gall bladder is attached quadrate lobe and the caudate lobe is placed to
10
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the posterior surface. Liver is very perfused organ with high blood flow which is
needed for delivering oxygen. Three main vessels are placed in the liver; hepatic
artery, hepatic portal vein and central vein (A.C.Guyton 2006). Liver is supplied
with blood from two different sources. Hepatic artery carries around 30% of the
blood while the portal vein, which is much thicker then artery, gives around 70%
of blood. This division is described as an arterial flow fraction (J.Sear 1992).
Figure 2.6: Structure of liver lobule with cellular plates, blood vessels, bile collecting system
and lymph flow system. (A.C.Guyton 2006)
Hepatic artery comes from heart and carries oxygen into the liver. Portal vein,
supplies liver with nutrients from gastrointestinal tract, but also toxins and partly
deoxygenated blood. Liver releases nutrients back into the blood through sinu-
soids and central vein. Liver contains 3 main components; sinusoids, hepato-
cytes and bile canaliculus. Blood from hepatic artery and portal vein enters
the sinusoids. Sinusoidal cells are open porous blood space. Around them are
tightly packed hepatocytes which enables easy access to the blood. The hepatic
sinusoids mix and send blood to a central vein from where it flows through a
hepatic vein into the inferior vena cava. Blood flow and bile flow are in oppo-
11
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site directions. Sinusoidal cells also contains Kupffer cells which remove dead
blood cells, bacteria and other toxic material that enter the sinusoids. Between
sinusoidal cells and hepatocytes is separation called space of Disse. Hepatocytes
build liver and they take up around 80% of total liver volume (OpenStax College
2013). These cells have more that one role in the liver. They are involved in pro-
tein anabolism and catabolism in zone in which they receive high oxygenated
blood, but if they are placed in zone with poor oxygenated blood, they will pre-
form biotransformation of drugs. The products of the hepatocytes, like bile and
bilirubin, will be drained into the bile canaliculus and to the bile duct, while
proteins and lipids will be extracted to sinusoids or stored up in cells (J.Sear
1992).
2.4 Gadolinium contrast agents
Every voxel has signal whose strength is represented with grey scale, lighter
voxels represent stronger signals. The contrast in MR images is showing differ-
ences between tissues. If pictures are T1 weighted the water will be shown dark
and the fat light. On T2 weighted pictures both fat and water are shown light.
Depending on the tissue which we want to examine we have to use certain way
of imagining. To have stronger contrast between the tissues it is possible to use
contrast agent which is changing T1 and T2 relaxivity of the tissue. First de-
veloped liver specific contrast agents had role to improve contrast to noise ratio
between metastases and healthy liver tissue. Since lesions have less functional
hepatocytes which can not exert uptake of contrast media, signal in these areas
will be decreased. Depending on the way of accumulation and concentration in
the tissue we can make conclusions about perfusion and diffusion in body. There
are positive contrast agents which have increasing signals and negative contrast
12
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agents with decreasing signals. Most of contrast agents are positive and based
on Gd3+ which is paramagnetic metal. Gadolinium has seven unpaired electrons
which also have spin and magnetic moment which is 657 times stronger then the
one of proton. The interaction between gadolinium and hydrogen atoms allows
fast releasing of protons energy and thus better relaxation. Because of recovery
of longitudinal magnetization signal in T1 images is increasing (Zylka 2013).
Ionic gadolinium has toxic effect on muscles and blood so that we could use
it, it has to be in molecular state which would prevent uptake of gadolinium.
The binding does not take place via a chemical bond, but by an inclusion of the
gadolinium ion in a molecular envelope. The chemical composition of Primo-
vist, Gadolinium based contrast agent also called gadoxetate disodium, is shown
in figure below. Liver specific contrast agents are used for detection and mor-
phological characterization of lesions but also for anatomy and function of the
liver.
There is a difference between intravascular and extravascluar contrast agents
whose kinetics are determinated only by perfusion and diffusion, and also me-
tabolizable contrast agents which are taken up by the Kupffer cells. This contrast
agent has two kinetic phases; distribution and elimination. It can be adminis-
trated as intravascular bolus and it enables the imagining of vascular structures
and focal lesions. While contrast agent is distributing in the compartments it is
possible to preform imagining of hepatic artery and portal vein phase. Gado-
cetic acid is actively transported from sinusoidal cells via organic anion trans-
porting polypeptide into the hepatocytes. After that they are excreted in biliary
canaliculi. Because of these characteristic it provides anatomic and functional
information about liver diseases (Yee Liang Thiana 2013). The plasma half life
of Gd-EOB-DTPA is approximately 56 minutes in patients with healthy liver.
Experiments which are preformed on rat’s livers shown that T1 relaxivity of
13
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Figure 2.7: 2D structure of Primovist (Pubchem)
.
Gd-EOB-DTPA in liver is 16.6 L/mmol and in blood 11.2 L/mmol (Bernard E.
Van Beers 2012).
14
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3.1 Motion correction
During the acquisition time, due to patient’s breathing, organs are changing their
position and shape. For data processing, it is necessary to average the voxels sig-
nals from different liver voxels and that process requires one position of the liver.
With software ProSoma is preformed an elastic motion correction of the static
and dynamic images. In automatic coregistration, coregistration is performed
based on normalized mutual information. For reference image we selected T1-
weighted high-resolution VIBE sequence. The aim is to couple the high res-
olution of the VIBE sequence with the functional information of the dynamic
sequence.
Voxel-based motion correction compares the gray value information of the two
data sets. Used metric is based on entropy, which is a measure of the uncer-
tainty of the occurrence of a particular event from a group of events. Event
represents the occurrence of a gray value, while the probability that this event
occurs is the relative frequency of the gray value. The overlap of the entropies of
both sets of images provides the information. This is called a common entropy.
Thus, for each combination of gray values occurring in the overlapping area of
both images, it is necessary to determine the relative frequency with respect to
all gray value combinations. It is possible to overlap the images with a very
15
3 Methods
small entropy or decreasing entropy of the secondary data set. The common
information of both images, that is, the overlap, is maximized to minimize the
common entropy. This ensures a more stable coregistration, but is not yet free
from misregistration which occurs when the individual entropies change more
than the common entropy. The avoidance of these errors is achieved with using
the normalized mutual information (NMI), which is determined by the following
equation:
NMIRef,Sek =
HRef +HSek
HRef,Sek
(3.1)
where HRef is the entropy of the primary reference data and HRef is entropy of
the secondary transformed data. (Butzek 2014)
Figure 3.1: Motion correction in ProSoma; Primary data (first row) and secondary data (second
row).
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There is a possibility for choosing between Fast and High Quality motion cor-
rection. If case of High Quality, a second calculation step is carried out after
coregistration by means of NMI, which coregistrates the images on the basis of
their intensity values. This leads to errors in multimodal image data, so only the
Fast option was used. (Butzek 2014)
Figure 3.2: Settings for motion correction in ProSoma.
3.2 Creating ∆R1 maps
Contrast agent signal intensity in tissue depends on the concentration of the
agent. Signal intensity depend on the pulse sequence, acquisition duration and
homogeneity. Signal increases with CA concentration and it is shown in ∆R1
map. Signal changes from T1 weight images enable calculating concentrations
and producing contrast time curves. Maps of proton density M0 and longitudi-
nal relaxation rate R10 maps were calculated using 5 sets of GRE images with
different flip angles
s(α) = M0sinα
1− E10
1− cosαE10 (3.2)
where α = 5◦, 10◦, 20◦, 30◦, 35◦.
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R1(t) maps represent four-dimensional longitudinal relaxation rate is calculated
from dynamic data sets prom pre-contrast and post-contrast T1 weighted images
using equation
R1(t) = − 1
TR
ln
1− (A+B)
1− cosα(A+B) , (3.3)
where α=35◦,
A = S(t)− S(0)
M0sinα
(3.4)
and
B = 1− E101− cosαE10 (3.5)
while S(t) and S(0) are signal intensity of 4D T1 weighted images (Ka-Loh Li
2000).
3.3 Selection of region of interest (ROI) and extraction
of signal time curves
Next step in analysis of MR images is defining specific areas of liver and blood
vessels. Since it is possible to distinguish tissues by signal strength, setting the
threshold show ’active’ regions. ROIs are defined by structural or functional
features. Structural ROIs are based on anatomy and the best way to get them
is to define them for each subject. Functional ROIs are based on analyzing
individuals. Common approach is to use scan to identify and compare voxels
and their response in different manipulations (Poldrack 2007).
There is several different methods for extraction of ROIs. When selecting areas
it is important not to include border zone voxels which can have influence in
partial volume effect. Because of high flow in the middle of the vessels signal is
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also higher so for the best balance it is also necessary to include voxels closer to
vessel walls. Selection can be preformed manually from different types of im-
ages and semi-automatic based on anatomy maps and tractography (Ylva Lilja
2016).
While selecting ROIs I combined anatomy characteristics with setting thresh-
old of signal intensity on typical values for certain tissue and then manually
selected ROI. Relaxivity value R1 in blood at magnetic field strength of 1.5 T
for Primovist is 7.3 L/mmol*s (Martin Rohrer 2005). During passage of first
and second bolus relaxivity values are considerably higher and because of this I
relied on anatomical features. From ∆R1 maps I extracted time steps in which
intensity of certain area was the highest. On extracted file I marked one test area
with full blood volume for material statistic in which I could saw minimum and
maximum intensity of signal. These values were used for setting threshold and
masking specific areas which I included in ROI. Once when threshold is setted
it is easy to mark ROI through slices (Figure 3.4.
Figure 3.3: Display and Masking settings in software Amira52. Threshold is setted from mini-
mum to approximately maximum values from test area.
From every ROI one signal time curve S(t) can be calculated, with time signal
drop during the CA passage, by averaging all voxels signals in the region. Signal
time curves can later be converted into the concentration time curves C(t) which
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Figure 3.4: Purple areas represent masked signals. These areas are only possible for marking
but it is necessary choose only ones which surely represent certain tissue.
represent concentration of CA in the blood. Equation used for converting signal
time curves which came from ∆R1(t) maps into concentration curves is
C(t) = R1(t)−R10<1 , (3.6)
where R1(t) is
R1(t) = 1
T1(t) . (3.7)
<1 is relaxivity of Gd-DTPA-BMA and R10 baseline relaxation signal intensity.
T1 is value of longitudinal relaxation rate (Ka-Loh Li 2000). Relaxivities used
in calculations are taken from literature (Bernard E. Van Beers 2012).
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3.4 Gamma variate function
Gamma variate function is function which is used for describing passage of
contrast media bolus through vessels and tissue. It is used for fitting process of
the signal time curves of arterial input function and portal vein input function.
The gamma variate function is expressed as:
γ(t) =

A(t− t0)αe(−
t−to
β ), t > t0
0, t ≤ t0
(3.8)
where t represent time and t0 delay time from t = 0 to the beginning of the
slope on the curve. In our case t0 is the time between injection of CA and
appearance of the bolus in the liver. In fitting process, A,α and β are setted as
free parameters. A is magnitude of the curve. α and β affect on the slope of
the fit in first bolus pass, but also on location and amplitude of the maximum
(Madsen 1992).
Signal time curves consist of first bolus pass, second bolus pass and saturation.
Second bolus and saturation are consequence of the recirculation of the CA in
the human body after the first bolus. Usually, second bolus arrive 15 to 20
seconds after first bolus. (Thomas Benner 1997). Concentration in blood plasma
is sum of first componentCp,b(t) and secondCp,mix(t) component when contrast
agent is well mixed in blood. Concentration of CA in blood during first pass
bolus is usually fitted with Gamma-variate function.
Cp,b(t) =

Cb,0(t− t0)αe(−
t−to
β ), t > t0
0, t ≤ t0
(3.9)
Like in Gamma variate function, Cb,0 represent magnitude of the curve. α and β
determine the slope first bolus pass. The second component of single time curve
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can be shown as single exponential increase and biexponential decrease.
Cp,mix(t) =

∑
i=s,f Cmix,i0(1− e−ψ(t−to−∆t))e−χi(t−to−∆t), t > t0 + ∆t
0, t ≤ t0 + ∆t
(3.10)
α, β, ψ and χ are fitting parameters which describe the time course. ∆t is time
shift between first and second bolus (L. Lüdemann 2000).
Code in Appendix A represent loop for fitting arterial signal time curves. Gamma
variate function was used for first and second bolus. Modified equation for sec-
ond bolus was used for saturation. For fitting portal vein signal time curves is
also used Gamma variate function but only for one bolus and saturation. Main
part of the code is in Appendix A. Curves and their fits are shown on Figure
3.5.
3.5 Pharmacokinetic modeling in MRI
Clinically applied semi-quantitative pharmacokinetic models which result in
physically unclear transport parameters for tracers used in dynamic contrast en-
hanced MRI were developed in 1990s (Tofts u. a. 1999). Models of the newer
generation use parameters as perfusion and capillary permeability.
An indicator is substance which yields physiological informations about the sys-
tem and tracer is type of indicator which is chemically identical to system but
detectable from system. MR contrast agents (CA) are indicators but not a trac-
ers. Assuming that some tissue has inlets and outlets carrying the substances,
transit time is time between entrance of the particle in and exit out of the tis-
sue. Probability distribution of transit times is represented by H(t) and the
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Figure 3.5: Results of fitting AIF and PVIF signal time curves (Patient 9)
mean transit time (MTT) is the expectation value of H(t). Tissue concentration
C is the amount of contrast agent in the sample divided by the volume of the
sample. It is possible to use normalized volume of distribution v and define a
concentration c(t) as amount of contrast agent in the sample divided by volume
of distribution v what is showed in relation
C(t) = vc(t). (3.11)
The flux of contrast agent which is transported through the tissue is described
like amount of contrast agent per unit of time. Change of amount of total CA in
the blood is difference between total influx ∑ Ji(t) and total outflux ∑ Jo(t). If
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we apply law of conservation on the flux definition we will get
dC(t)
dt
=
∑
i∈inlet
Ji(t)−
∑
o∈outlets
Jo(t)· (3.12)
Definition of compartment is well-mixed space where the concentration is spa-
tially uniform within the volume of distribution. In compartment model the
influx of contrast agent can be defined as flow F multiplied with concentration
c(t). By combining this with equation for conversation of the flux we get
v
dc(t)
dt
=
∑
i∈inlet
Fici(t)−
∑
o∈outlets
Foco(t)· (3.13)
Capillary models, except venous outlet, assume leakage of CA through capillary
walls what is actually second outlet of CA into the extravascular extracellular
space (EES). The permeability P represents outflux of CA per unit wall area
and per unit concentration and it is approximately same along the capillary wall.
In that case outflux through capillary wall Jl(t) is the product of permeability-
surface area and average concentration of CA. (S.P.Sourbron 2011a)
3.5.1 One compartment model
One of the capillary models is compartment model which assume that capillary
bed is compartment. cp represent the concentration of CA in vp so the leakage
flux which goes from capillary wall to EES is product of surface permeability
PS and concentration cp(t)
Jl = PScp(t). (3.14)
If we assume that flux of CA in plasma volume is equal to sum of the influx,
outflux and permeability outflux we will get balance equation for compartment
model:
vp
dcp(t)
dt
= Fpcp(t)− Fpcp(t)− PScp(t). (3.15)
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Fp
PS
Fp
vp
Figure 3.6: Compartment model
3.5.2 Tissue uptake model (TU)
PS
vp
vEES
Figure 3.7: Tissue uptake model
The tissue uptake model is special case of
two-compartment exchange model, but we as-
sume that in this case there is no exflux of CA
from EES back to plasma. Since the outflux
of CA to EES is inconsiderable small, mean
transit time Te is longer then time of mea-
surement so that parameters Te and ve can not
be measured precisely. Also, concentration of
CA in plasma volume is much larger than that
in the EES volume because only inlet to EES
is through capillary wall. Mass balance equa-
tion for TU model is expressed like:
ve
dce(t)
dt
= PScp(t) (3.16)
where ce represent concentration in interstitial volume ve (Jesper F. Kallehauge
2017).
3.5.3 Dual-inlet two-compartment uptake model
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Figure 3.8: Dual-inlet two-compartment uptake model
Two region models assume
that CA is passing from one
compartment into another; it
will be extracted from ves-
sels through the capillary
wall to EES and cells.
Since is well known that ga-
doxetic acid is taken up by
hepatocytes from plasma i.e.
sinusoidal cells instead of
plasma volume and volume
of extracellular extravascu-
lar space, it will be used si-
nusoidal volume and hepatocytes volume. Contrast agent have 2 inlets; arterial
and venous (S.P. Sourbron 2012). Main contribution comes from venous plasma
flow fv, but signal in liver is increased before bolus in portal vein. To sum up
arterial and venous flows we have to implement new parameter fa; arterial flow
fraction:
cs(t) = faca(t) + (1− fa)cv(t). (3.17)
This expression turns two-inlet model into single-inlet model. Model assume
that arterial input function (AIF) is sampled directly in capillary bed but in prac-
tice arrival is delayed. It is obvious in case of poor fit and it can be corrected
with artery and venous delay;
c(t) = c(t− T0). (3.18)
Surface permeability is included in model as uptake rate Ki of contrast agent
from sinusoids to hepatocytes (S.P.Sourbron 2011a). Concentration of contrast
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agent in vs and vh can be described by combining equations for compartment
model and tissue uptake model.
vs
dcs(t)
dt
= Fa+vca+v(t)− Fa+vcs(t)−Kics(t) (3.19)
vh
dch(t)
dt
= Kics(t) (3.20)
Main part of fitting routine is placed in Appendix A.
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Figure 3.9: Results of fitting liver tissue signal time curves with dual-inlet two-compartment up-
take model [600 s]; since this model describe only uptake of CA acquisition duration
is setted to only five minutes; (Patient 9)
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3.5.4 Dual-inlet two-compartment uptake model with extraction
rate Ke
Gadoxetic acid has to be extracted from hepatic cells into the biliary pathway.
Parameter Ke is describing the excretion of contrast agent. Extraction rate is
much smaller than uptake rate because of filtration of blood from toxic and
unnecessary components.
Ki
FA vs
FV
vh
FV+FA
Ke
Figure 3.10: Dual-inlet two-compartment uptake model with extraction rate Ke
The arterial flow fraction and extraction rate can be included in equations used
for dual-inlet two-compartment model. We get set of equations which are con-
sist of 6 fitting parameters; sum of arterial and venous flow (Fa+v), sinusoidal
volume (vs), uptake rate (Ki), hepatocytes volume (vh), arterial flow fraction
(fa) and extraction rate (Ke).
vs
dcs(t)
dt
= Fa+v(faca(t) + (1− fa)cv(t))(t)− Fa+vcs(t)−Kics(t) (3.21)
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vh
dch(t)
dt
= Kics(t)−Kech(t) (3.22)
Because of complexity of the model I excluded delay from fitting parameters
and set it as constant; Delaya = 1 and Delayp = 1. It is necessary to include
delay of one second into the fitting process to get more correct values of other
fitting parameters. Values ca(t) and cv(t) are taken from fitted AIF and PVIF
signal time curves at every single time point t.
The total concentration C is the combination of concentration of CA in the si-
nusoidal volume, cs and the hepatocytes volume, ch:
C(t) = vscs(t) + vhch(t). (3.23)
In Appendix A it is placed main part of fitting routine and Figure 3.11 shows
data curve and fitting curves. This model describe uptake and extraction of CA
and acquisition duration is around 15 minutes.
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Figure 3.11: Results of fitting liver tissue signal time curves with dual-inlet two-compartment
uptake model with extraction rate (Patient 9)
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4.1 Patients
A study was conducted to examine patients with various malignant disease in
liver that required portal vein embolization. This method is useful in cases when
surgical tumor removal is not possible due to the size or location of the tumor
without maintaining sufficient residual function of the liver. In this type of in-
tervention individual branches of the portal vein are mechanically closed in or-
der to prevent the high blood supply in the malignant area. As a result highly
blood-perfused, healthy portion attempts to compensate for the diminished over-
all function and grows steadily. Once sufficient size and function of the healthy
liver lobes are present, the malignant areas can be surgically removed without
unduly compromising liver function as a result of the surgery.
Patients have been advised of possible risks and have submitted a statement of
consent for the use of their data for research purposes. Several anatomical and
dynamic sequences were performed, both with and without contrast medium.
The total examination time should not exceed 45 minutes as far as possible. For
my research I used data of 12 patients where 6 of them are female and 6 male.
All of them had primary tumor of the liver or metastases on the liver.
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Table 4.1: Informations about patients age, sex and acquisition duration
Patient Age Sex Aquisition duration[s]
Patient 1 59 Female 1900
Patient 2 55 Female 1600
Patient 3 66 Male 1900
Patient 4 69 Male 1700
Patient 5 59 Male 1600
Patient 6 71 Male 1550
Patient 7 48 Male 1500
Patient 8 65 Female 1800
Patient 9 56 Female 1900
Patient 10 59 Female 1600
Patient 11 70 Female 1700
Patient 12 68 Male 1700
4.2 MR sequence
All images were taken in a MR tomograph from Siemens at 1.5T magnetic
field strength. As a transmitting and receiving coil was used a combination
of a Siemens 6-channel body coil and the table coil of the MR scanner. For
each patient’s study, 19 different MR sequences were used for both anatomi-
cal and dynamic imaging. For evaluation, seven gradient echo sequences were
used, which are subsequently broken down after the time of recording. The first
five sequences were run before the contrast agent administration. These are the
TWIST21 sequences required for the excitation angle method with excitation
angles of 5◦, 10◦, 20◦, 30◦ and 35◦.
The sixth sequence is the dynamic sequence. It is divided into three shots before
contrast administration and 135 shots taken during and after contrast administra-
tion. The time interval between two images is on average 3.4 seconds. Longer
recording pauses in the dynamic sequence were used to drive anatomical se-
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Table 4.2: Sequence parameters of all sequences used for data evaluation
Sequence number 1-5 6 7
Sequence
type
TWIST TWIST VIBE
static dynamic static
Flip angle 5◦, 10◦, 20◦, 30◦, 35◦ 30◦ 10◦
TR 2,33ms 2,33ms 2,33ms
TE 0,84ms 0,84ms 0,84ms
Acquisition matrix 205 x 256 205 x 256 338 x 512
Image resolution 256 x 72 x 256 256 x 72 x 256 512 x 60 x 512
K-Space rows 24 24 24
quences. The duration from the recording of the first to the last dynamic image
data set was about 20 minutes. The number and order of shots has been pre-
set, the duration of the breaks varies depending on the patient and the personnel
performing the task.
The seventh sequence is an anatomical T1-weighted VIBE22 sequence. It was
made 20 minutes after contrast administration. This recording is taken with
breath hold and serves as a reference recording for movement correction of the
liver.
4.3 Methods evaluation
For evaluation of methods I compared mean root squares (RMS) of fitted curves
with F-test. It is hypothesis test used for comparing two models from witch one
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of them is simpler and other more complex. In equation
F = (SSs − SSc)/SSc(DFs −DFc)/DFc (4.1)
DF = N − K represent degree of freedom where N is the number of data
points and K is the number of free parameters. If the simpler model is correct
F-test result is around 1. If the ratio is much greater than 1, more complicated
model is correct or the simpler model is correct, but more complicated model to
fit better. If the P value is low, more complex model is statistically significantly
better (P. Kletting 2009).
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For examination of liver function of 12 patients I used two methods; dual-inlet
two-compartment uptake model (2CUM) and dual-inlet two-compartment up-
take model with extraction rate (2CUMEX). All patients were successfully im-
aged and analyzed. These models had some variations in acquisition duration
and boundaries for fitting volume parameters. Since volume of hepatocytes and
sinusoidal cells are known from the literature (vh = 74%, vs = 16%) these could
be setted as fixed value instead of fitting parameters (Renz 2003). In addition to
get better fit I also setted volumes as parameters with low boundaries (5% from
literature values) and high boundaries (30% from literature values). 2CTUM
was used in 2 different acquisition duration; 600 s and 1700 s (mean value of
acquisition duration for every patients), while 2CTUMEX had to use all time
points because of extraction which demands more time then just and uptake.
Values of RMS in embolised and nonembolised tissue and degrees of freedom
for every model are shown in Table 5.1.
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Table 5.1: Root mean square values and degrees of freedom
2CUM[600s]
Fixed vh, vs Fitted vh,vs(LB) Fitted vh, vs (HB)
Degree of freedom 60 58 58
RMSemb 0.00009669 0.00007690 0.00004481
RMSnemb 0.00012659 0.00012002 0.00005706
2CUM[AD]
Fixed vh, vs Fitted vh,vs(LB) Fitted vh, vs (HB)
Degree of freedom 65 63 63
RMSemb 0.00018343 0.00005870 0.00002292
RMSnemb 0.00015962 0.00015115 0.00005292
2CUMEX[AD]
Fixed vh, vs Fitted vh,vs(LB) Fitted vh, vs (HB)
Degree of freedom 64 62 62
RMSemb 0.00007674 0.00004369 0.00003064
RMSnemb 0.00004644 0.00004487 0.00002919
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It is necessary to have different degree of freedom for comparison of models
with F-test, and model with low fitting boundaries obviously have larger RMS
values, so I reject all results with low fitting boundaries and compare ones I got
with fixed values and high boundaries fitted values. Results are shown in Table
5.2.
Table 5.2: F-test values; upper results refers to embolised tissue and below on nonembolised
tissue
F-Test
Simpler method Complex method F-test result p value
2CUM [600] Fixed 2CUM [600] Fitted
33.57 <0.00001
35.33 <0.00001
2CUM [AD] Fixed 2CUM [AD] Fitted
220.61 <0.00001
63.51 <0.00001
2CUMEX [AD] Fixed
2CUMEX [AD]
Fitted
46.65 <0.00001
18.32 <0.00001
Results of F-test indicate that values we got with fitted parameters are better
because of low p-values. Next step was compare which one of models in case
of fitting volumes is the best. Results are show in Table 5.3.
F-test values point to the fact that 2CUM in acquisition duration of 600 seconds
better describes liver function. The reason is smaller number of fitting param-
eters and smaller degree of freedom. Since 2CUM does not describe contrast
agent extraction but only absorption, the excessive degree of freedom during
1700 seconds measurement caused a bad result in F-test with comparison to
2CUMEX. Still, 2CUMEX model gives pretty good fit, value of one more pa-
rameter and better describes longer acquisition time liver curves.
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Table 5.3: F-test values; upper results refers to embolised tissue and below on nonembolised
tissue
F-Test
Simpler method Complex method F-test result p value
2CUM [600] Fitted 2CUM [AD] Fitted
-12.04 -
-0.98 -
2CUM [600] Fitted
2CUMEX [AD]
Fitted
-7.17 -
-14.80 -
2CUM [AD] Fitted
2CUMEX [AD]
Fitted
-15.61 -
50.40 <0.00001
5.1 2CUM[600 s]
Mean value and SD from 2CUM in acquisition duration of 600 s of perfusion
(total plasma flow per blood volume) is 65.5±32.1 for nonembolised tissue and
26.2±15.7 for embolised tissue what we can see in Table 5.4. There is significant
difference between perfusion in liver tissues (P=0.001) what means that nonem-
bolised tissue is highly perfusion compared to embolised. Extracelular volume
in nonembolised and embolised tissue is 29.5±6.3 and 22±6.9. Hepatocytes
volume contains 63.1±4.6 in nonembolised and 65.3±4.4 in embolised. Sinu-
soidal volume differences between tissues are significant (P=0.01) but there is
no difference when it comes to hepatocytes volume. It is to be expected that the
sinusoidal volume, which represent the blood volume, will be greater in nonem-
bolised tissue because it is more perfused. Uptake rate is significantly bigger in
nonembolised tissue (P<0.00001); 7.9±3.4 and 1.9±1.2 for embolised. Values
are in range with literature values (S.P. Sourbron 2012). Arterial flow fraction
in embolised tissue is always 100 while in nonembolised tissue 22±19.4. Figure
5.1 shows results in boxplots.
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Table 5.4: Statistical results for 2CUM[600s]
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 62.8 20.6 31 20.7 61.9 65.3
Mean 65.5 26.2 29.5 22 63.1 65.3
Standard deviation 32.1 15.7 6.3 6.9 4.6 4.4
Ki[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb
Median 7.6 2.2 18 100
Mean 7.9 1.9 22 100
Standard deviation 3.4 1.2 19.4 0
5.2 2CUM[AD]
The dual-inlet two compartment model gives values for perfusion 38.2±19.4
and 26.3±15.6 for nonembolised and embolised tissue (Table 5.5). There is no
significant difference between tissues flow (P=0.11) what telling us one more
time that this fit does not describe data good enough because it is not possible
to distinguish liver parts. T-test of root mean square between tissues confirms
this fact (P=0.006). Fits are not good for one of the tissue, in this case for
nonembolised. Values for volume and arterial fraction in nonembolised part of
the liver are hitting lower and upper boundaries, probably because this model
can not describe saturation perfectly. Volume of sinusoidal cells and uptake
rate is again larger in nonembolised tissue (P<0.0001) and hepatocyte volume is
smaller in nonembolised part (P=0.02).
With dual-inlet two compartment model in duration of approximate 1700s is
possible to check dependence of parameters on time acquisition. Literature in-
dicates that with increase of acquisition duration parameter values will increase
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Figure 5.1: Parameters values given with dual-inlet two compartment model in acquisition du-
ration of 600 s
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Figure 5.2: Results of fitting liver tissue signal time curves with dual-inlet two-compartment
uptake model [1900 s]; on the graph it is able to notice deviation between data and
fitted curve in saturation (Patient 9)
or decrease (Leonidas Georgiou 2017). Parameters which reflects physiologi-
cal processes that occur at the beginning of imaging process, like perfusion and
uptake rate, decreased with with acquisition duration. Differences between ac-
quisition duration for 2CUM are shown in nonembolised healthy tissue; value of
perfusion reduced on 38.2±16.4 with increased time (P=0.001). There is slightly
difference between uptake rates obtained with 2CUM[600] and 2CUM[AD] in
nonembolised part of the liver but p-value indicate that difference is not sig-
nificant (P=0.12). By increasing duration, mean arterial flow fraction largely
increased on 46.8±8.6 against the value in last case (P=0.001). This value is
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Figure 5.3: Parameters values given with dual-inlet two compartment model in acquisition du-
ration of 1700 s
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obviously incorrect. Other values for both embolised and nonembolised part
of the liver, like volumes, remains the same despite the change of acquisition
time (P>0.05) but if fitting space was larger, differences would probably grow.
Larger acquisition time will be more important in case of extraction rate estima-
tion. Figure 5.3 shows results for embolised and nonembolised tissue in box-
plots, while Figure 5.4 shows differences in perfusion and arterial flow fraction
in dependence of acquisition duration.
Table 5.5: Statistical results for 2CUM[AD]
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 34.4 19.8 35 19.6 60 63.4
Mean 38.2 26.3 32.7 20.7 61.4 65.9
Standard deviation 19.4 15.6 3.6 6.9 2.7 6.1
Ki[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb
Median 5.9 2.3 50 100
Mean 6 2.2 46.8 100
Standard deviation 2.3 0.8 8.6 0
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Figure 5.4: Comparison of the values of perfusion and arterial flow fraction in nonembolised
tissue depending on acquisition duration
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5.3 2CUMEX[AD]
Double-inlet two compartment uptake model with extraction rate describes sig-
nal time curves with six parameters. This model use whole acquisition duration,
maximal and different for every patient (approximate 1700 seconds). Results
for this model are shown in Table 5.6. Perfusion is 69.7±32.3 and 26.7±15.9
for nonembolised and embolised tissue. These values are significantly different
(P=0.004). From all wide space fitting methods, this one gives values for si-
nusoidal volume closest to literature values; 28±6.9 and 20±6.3. Like in every
case values are bigger in nonembolised tissue (P=0.007). Hepatocytes volume
is 63.7±3.9 for nonembolised and 73.4±6.9 for embolised. Difference between
volumes is also statistically significant (P=0.0003). Uptake rate and extraction
rate in embolised tissue is minor compared to nonembolised tissue (P<0.0001).
Values for uptake rate are 9.4±3.9 and 2.4±0.9 and for extraction rate 2.7±1.6
and 0.2±0.4. Arterial flow fraction is 20.6±19.7. Standard deviation is pretty
big, like in 2CTUM[600], what means that values are widely spread. All results
are represented graphically in Figure 5.5
45
5 Results and discussion
Table 5.6: Statistical results for 2CUMEX[AD]
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 71.6 20.5 28.8 19.5 62.8 73.7
Mean 69.7 26.7 28 20 63.7 73.4
Standard deviation 32.3 15.9 6.9 6.3 3.9 6.9
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 9 2.4 2.3 0.06 14.3 100
Mean 9.4 2.4 2.7 0.2 20.6 100
Standard deviation 3.9 0.9 1.6 0.4 19.7 0
Table 5.3 shows that embolised tissue is better described with 2CUM[AD] but
for nonembolised tissue curves are better fitted with 2CUMEX[AD]. When
comparing parameters obtained by these two models, there is no statistically
significant difference between values in embolised tissue. Only significant dif-
ference is hepatocytes volume (P=0.009). Hepatocytes volume obtained with
2CUMEX[AD] and literature value (vh = 74%) considered to be not statisti-
cally significant. In other words, 2CUMEX model gave more correct value then
2CUM[AD].
When comparing parameter values obtained with 2CUM[600] and 2CUMEX[AD]
there is no significant difference between them in both embolised and nonem-
bolised tissue. Only difference is hepatocyte volume (P=0.002) witch is more
correct in 2CUMEX[AD]. For most of the parameters, it is not possible to be
sure about correct value, but advantage of this model is that it distinguish all
values for embolised and nonembolised tissue; there is no difference in RMS
value between tissues (P=0.8).
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Figure 5.5: Parameters values given with dual-inlet two compartment model in acquisition du-
ration of 600 s
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5.4 Comparison of parameters between methods
Results obtained with dual-inlet two-compartment uptake model (Sourbron model)
without delay as fitting parameters gave next results for the total plasma flow;
F=69±30, extracellular (sinusoidal) volume; vs=15±5,5, uptake rate Ki=3.5±2
and arterial flow fraction fa=10±15. This model is applied on 600 seconds of
acquisition duration and only difference between this and 2CUM[600] is hepa-
tocytes volume as fitting parameter (S.P. Sourbron 2012).
In Table 5.7 it is possible to notice that results for embolised tissue is much more
stable and smaller than in nonembolised tissue. Nonembolised tissue results are
pretty different for each model. In case of fixed or small fitting span (LB) for
volume, all models give up to four times larger values then in literature. High
fitting span (HB) gives results pretty similar to literature values; there is no
significant difference between perfusion values obtained with 2CUM[600](HB)
or 2CUMEX[AD](HB) and literature (P=0.7, P=1), but there is difference in
case of 2CUM[AD](HB) (P=0.002).
Table 5.7: Comparison of perfusion
F[ml/min/100ml]
Method
Mean ±SD
NEmb Emb
2CUM[600s], Fixed vh, vs 158 ±198.6 30±20.5
2CUM[600s], Fitted vh, vs (LB) 141±162.9 30.5±19.1
2CUM[600s], Fitted vh, vs (HB) 65±32.1 26.2±15.7
2CUM[AD], Fixed vh, vs 54.4±30.2 31.5±23.7
2CUM[AD], Fitted vh, vs (LB) 53.1±29.9 31.6±21.6
2CUM[AD], Fitted vh, vs (HB) 38.2±19.4 26.3±15.5
2CUMEX[AD], Fixed vh, vs 337.1±494.2 30±20.2
2CUMEX[AD], Fitted vh, vs (LB) 319.2±511.4 29.8±20.3
2CUMEX[AD], Fitted vh, vs (HB) 69.7±32.3 26.7±15.9
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When it comes to volume, best result are obtained with models in case of smaller
fitting space (LB), but at the same time these models are bad for others param-
eters (Table 5.8, Table 5.9). Methods which were using large fitting span (HB)
gave real fitted parameters but there is significant difference from literature val-
ues (P>0.05). The role of this fitted parameters was to give freedom to the
model. Past researches (Jian-Feng Yang 2016) showed that Tofts models are
much more stable in measuring the volume, while dual-input two-compartment
model is more accurate in measuring perfusion.
Table 5.8: Comparison of sinusoidal volume
vs[%]
Method
Mean ±SD
NEmb Emb
2CUM[600s], Fixed vh, vs 16 16
2CUM[600s], Fitted vh, vs (LB) 16.7±0.5 16.4±0.7
2CUM[600s], Fitted vh, vs (HB) 29.5±6.3 22±6.9
2CUM[AD], Fixed vh, vs 16 16
2CUM[AD], Fitted vh, vs (LB) 16.8 16.2±0.8
2CUM[AD], Fitted vh, vs (HB) 32.7±3.6 20.7±6.9
2CUMEX[AD], Fixed vh, vs 16 16
2CUMEX[AD], Fitted vh, vs (LB) 16.5±0.6 16.2±0.8
2CUMEX[AD], Fitted vh, vs (HB) 28±6.9 20±6.3
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Table 5.9: Comparison of hepatocyte volume
vh[%]
Method
Mean ±SD
NEmb Emb
2CUM[600s], Fixed vh, vs 74 74
2CUM[600s], Fitted vh, vs (LB) 73.9±2.5 74±2.1
2CUM[600s], Fitted vh, vs (HB) 63.1±4.6 65.3±4.4
2CUM[AD], Fixed vh, vs 74 74
2CUM[AD], Fitted vh, vs (LB) 74.2±2.4 72.3±1.6
2CUM[AD], Fitted vh, vs (HB) 61.4±2.7 65.9±6.1
2CUMEX[AD], Fixed vh, vs 74 74
2CUMEX[AD], Fitted vh, vs (LB) 74.6±2.2 75±2.3
2CUMEX[AD], Fitted vh, vs (HB) 63.7±3.9 73.4±6.9
In Table 5.10 we can see that 2CUM[AD] case give extremely high values for
arterial flow fraction and they are hitting upper boundary in fitting span. All
values obtained with 2CUM cases pretty differ from literature (P<0.05). Values
obtained with 2CUMEX cases are not significantly different then values ob-
tained with Sourbron model (P>0.05). Between them, 2CUMEX[AD] fixed and
2CUMEX[AD](LB) are most similar to literature values (P=0.9).
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Table 5.10: Comparison of arterial flow fraction
fa[%]
Method
Mean ±SD
NEmb Emb
2CUM[600s], Fixed vh, vs 24.8±23.6 100
2CUM[600s], Fitted vh, vs (LB) 25.2±23.6 100
2CUM[600s], Fitted vh, vs (HB) 22±19.4 100
2CUM[AD], Fixed vh, vs 48.1±4.7 100
2CUM[AD], Fitted vh, vs (LB) 48.4±3.8 100
2CUM[AD], Fitted vh, vs (HB) 46.8±8.6 100
2CUMEX[AD], Fixed vh, vs 9.5±16 100
2CUMEX[AD], Fitted vh, vs (LB) 9.7±15.3 100
2CUMEX[AD], Fitted vh, vs (HB) 20.6±19.7 100
5.5 Ki/Ke
Sourbron model without delay as fitting parameters obtain value of uptake rate
Ki=3.5±2 (S.P. Sourbron 2012). All values differ between embolised and nonem-
bolised tissue. There is extremely difference between all obtained values and
literature. HB cases from every method gave smallest result, but in general
2CUM[AD] obtained values most similar to the literature.
Liver function can be described as ratio between uptake rate and efflux rate.
This ratio could show is liver manage to preform it’s tasks and how fast it can
preform it. It quantifies the loss of contrast agent during its passage through
the liver. Comparing to literature values (Leonidas Georgiou 2017) on healthy
patients using same tracer (Ki=22±5 ml/min/100ml, Ke=1.7±0.6 ml/min/100ml
Ki/Ke=12.9), mine results are giving smaller ratios; showed in Table 5.13.
The reason for that are small Ki and high Ke values is that all patients in my
case suffer from primary cancer or metastases on the liver, what probably affect
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on decreasing of uptake rate and increasing of extraction rate.
Table 5.11: Comparison of uptake rate
Ki[ml/min/100ml]
Method
Mean ±SD
NEmb Emb
2CUM[600s], Fixed vh, vs 9.4±3.5 3.2±2.1
2CUM[600s], Fitted vh, vs (LB) 9.4±3.4 2.9±1.6
2CUM[600s], Fitted vh, vs (HB) 7.9±3.4 1.9±1.2
2CUM[AD], Fixed vh, vs 6.4±2.1 3.2±3.2
2CUM[AD], Fitted vh, vs (LB) 6.4±2.1 2.4±0.8
2CUM[AD], Fitted vh, vs (HB) 6±2.3 2.2±0.8
2CUMEX[AD], Fixed vh, vs 12.1±5.2 4.9±5.3
2CUMEX[AD], Fitted vh, vs (LB) 11.9±5.1 3±1.3
2CUMEX[AD], Fitted vh, vs (HB) 9.4±3.9 2.4±0.9
Table 5.12: Comparison of extraction rate
Ke[ml/min/100ml]
Method
Mean ±SD
NEmb Emb
2CUMEX[AD], Fixed vh, vs 5.5±3.4 1.9±2.1
2CUMEX[AD], Fitted vh, vs (LB) 5.5±3.5 1.2±1.5
2CUMEX[AD], Fitted vh, vs (HB) 2.7±1.6 0.2±0.4
Table 5.13: Ratio of uptake rate and extraction rate
Ki/Ke
Method NEmb Emb
2CUMEX[AD], Fixed vh, vs 2.2 2,5
2CUMEX[AD], Fitted vh, vs (LB) 2,2 2,5
2CUMEX[AD], Fitted vh, vs (HB) 3,5 12
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6 Conclusion
Most of the results I have obtained in this research are in range with the values
in literature. It is difficult to compare which method gives the most accurate
results. While comparing the methods, some of them showed bad on t-test, but
at the same time yielded results closer to the literature.
There was a lot of different settings in processing data and fitting routine which
could have effect on the finishing results. One of the most important, but also
demanding phase, was choosing ROI. There is no universal way for masking the
area on MR images and there has to be some deviations for each patient.
Besides that, big influence on the fitting procedure is delay time. In my case
delay was not fitting parameter because it was making the model very unsta-
ble. Researches has showed importance of including delay in modeling. It can
cause significant difference in perfusion and arterial fraction. This research is
made with dual-input single compartment model and they suggest using pre-
estimation of delays with constrained free modelling (Manil Chouhan 2016).
During modelling I tried to use similar technique to get results but since 2CUMEX
is complex method with more parameters whole model was unstable. In some of
past researches for accurately fit only arterial delay was used. Since both portal
vein and artery has delay, I included them as constant.
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One more thing that effect the fitting routine is time resolution which is in our
case one second. When using larger time resolution, I could not obtain good
fit. Original time resolution of data was around 3 seconds, but after interpola-
tion I set time resolution on 1 second which gave me satisfying fit with small
mistake.
It would be good if dynamic TWIST sequence had acquisition duration longer
then 1900 seconds. If endurance of imaging was 30 to 40 minutes I could see
better dependence of parameters on the time. Fitting routine with 2CUM in dis-
tinction of 1000 seconds showed significant difference between values 2 values;
perfusion and arterial flow fraction. One more advantage of longer endurance
would be more correct extraction rate because it would be possible to see how
long does the contrast agent retained in the liver.
When there is a need for distinguishing embolised and nonembolised tissue, best
model for this would be dual-inlet two-compartment uptake model with extrac-
tion rate. Results of t-test showed that there is significantly deviation between
parameter values in different tissue, what was the aim of my research.
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A Fitting codes
A.1 AIF signal time curve fitting routine
! deltat: time step
! deltazeit: arrival of the first bolus
! deltazeit2: arrival of the second bolus
! ampl: amplitude of the first bolus
! ampl2: amplitude of the second bolus
! SecBolWdth: manually input parameter witch enables manipulation of
the fit
! x(1): first bolus rise
! x(2): first bolus fall
! x(3): time of maximum of the first bolus
! x(4): first bolus intensity
! x(5): saturation intensity
! x(6): saturation fall
! x(7): saturation width - manually input parameter
! x(8): time shift of the exponential decay of saturation -manually
input parameter
! x(9): time of maximum of the second bolus
! x(10): second bolus intensity
! x(11): second bolus rise
! x(12): second bolus fall
do j=0,int(deltat(k))
deltazeit=zeit+dble(j)-x(3)+x(1)/x(2)
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deltazeit2=15+zeit+dble(j)-x(9)+x(11)/x(12)
! First bolus
if ((deltazeit.gt.0).and. (deltazeit.lt. 15)) then
if (j.eq.int(deltat(k))) then
ergeb=ergeb+(deltat(k)-int(deltat(k)))*ampl
*deltazeit**x(1)*dexp(-deltazeit*x(2))/deltat(k)
endif
else
ergeb=ergeb+ampl*deltazeit**x(1)
*dexp(-deltazeit*x(2))/deltat(k)
endif
! Second bolus
else if ((deltazeit.ge. 15).and. (deltazeit2 .lt. SecBolWdth))
then
if (j.eq.int(deltat(k))) then
ergeb=ergeb+(deltat(k)-int(deltat(k)))*ampl2*
deltazeit**x(11)*dexp(-deltazeit*x(12))/deltat(k)
endif
else
ergeb=ergeb+ampl2*deltazeit**x(11)
*dexp(-deltazeit*x(12))/deltat(k)
endif
! Saturation
else if (deltazeit2.ge. SecBolWdth) then
ergeb=ergeb+(deltat(k)-int(deltat(k)))+x(5)
*dexp(((15+SecBolWdth)-deltazeit)/x(6))
endif
enddo
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A.2 PVIF signal time curve fitting routine
! deltat: time step
! deltazeit: arrival of the first bolus
! ampl: amplitude of the first bolus
! SecBolWdth: manually input parameter witch enables manipulation of
the fit
! x(1): first bolus rise
! x(2): first bolus fall
! x(3): time of maximum of the first bolus
! x(4): first bolus intensity
! x(5): saturation intensity
! x(6): saturation fall
! x(7): saturation width - manually input parameter
! x(8): time shift of the exponential decay of saturation - manually
input parameter
do j=0,int(deltat(k))
deltazeit=zeit+dble(j)-x(3)+x(1)/x(2)
! First bolus
if ((deltazeit.gt.0) .and. (deltazeit .lt. SecBolWdth)) then
if (j.eq.int(deltat(k))) then
ergeb=ergeb+(deltat(k)-int(deltat(k)))*ampl
*deltazeit**x(1)*dexp(-deltazeit*x(2))/deltat(k)
endif
else
ergeb=ergeb+ampl*deltazeit**x(1)
*dexp(-deltazeit*x(2))/deltat(k)
endif
! Saturation
else if (deltazeit.ge. SecBolWdth) then
ergeb=ergeb+x(5)*dexp((SecBolWdth-deltazeit)/x(6))/deltat(k)
endif
enddo
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A.3 Fitting routine (2CUM)
% x0 initual values
% lb initual values for lower boundrey
% ub initual values for upper boundrey
% Finput
% vs
% Ki
% vh
% fa
% A, b are condition matrix for sum of hepatocytes and sinusoidal
volume
% tolx: convergevce tolerance on solution vector, if the solver
attempts to take a step that is smaller than tolx, the iterations
end
% tolf: convergence tolarance on function value
% createOptimProblem: creates an empty optimization problem structure
% fmincon: the type of solver and
% objective: function which accepts vector and returns a scalar
% MultiStart: solver attempts to find multiple local solutions
% UseParallel: distribute local solver calls to multiple processors
x0 = [ Finput vs Ki vh fa ];
lb = [ Finput_lb vs_lb Ki_lb vh_lb fa_lb ];
ub = [ Finput_ub vs_ub Ki_ub vh_ub fa_ub ];
A = [ 0 1 0 1 0 0 ];
b = [ 0.95 ];
tolx=1e-3;tolf=1e-6;
opts = optimset(’Algorithm’,’sqp’,’TolX’,tolx,’TolFun’,tolf);
problem = createOptimProblem(’fmincon’,’objective’,
@(x)SourbronM_Ke_ODE_func(x,time_data,signal_data,name,emb),
’x0’,x0,’Aineq’,A,’bineq’,b,’lb’,lb,’ub’,ub,’options’,opts);
ms = MultiStart(’UseParallel’,’always’);
[x RMS] = run(ms,problem,4000);
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for n = 1:length(t)-1
Cs(n+1) = (Finput/vs)*((1-fa)*pvif_corr(n)
+fa*aif_corr(n))*dt-Cs(n)*((Ki+Finput/vs))*dt+Cs(n);
Ch(n+1) = (Ki/vh)*Cs(n)*dt+Ch(n);
end
Cs = vs*Cs;
Ch = vh*Ch;
Ct = Cs+Ch;
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A.4 Fitting routine (2CUMEX)
% x0 initual values
% lb initual values for lower boundrey
% ub initual values for upper boundrey
% Finput
% vs
% Ki
% vh
% fa
% Ke
% A, b are condition matrix for sum of hepatocytes and sinusoidal
volume
% tolx: convergevce tolerance on solution vector, if the solver
attempts to take a step that is smaller than tolx, the iterations
end
% tolf: convergence tolarance on function value
% createOptimProblem: creates an empty optimization problem structure
% fmincon: the type of solver and
% objective: function which accepts vector and returns a scalar
% MultiStart: solver attempts to find multiple local solutions
% UseParallel: distribute local solver calls to multiple processors
x0 = [ Finput vs Ki vh fa Ke ];
lb = [ Finput_lb vs_lb Ki_lb vh_lb fa_lb Ke_lb ];
ub = [ Finput_ub vs_ub Ki_ub vh_ub fa_ub Ke_ub ];
A = [ 0 1 0 1 0 0 ];
b = [ 0.95 ];
tolx=1e-3;tolf=1e-6;
opts = optimset(’Algorithm’,’sqp’,’TolX’,tolx,’TolFun’,tolf);
problem = createOptimProblem(’fmincon’,’objective’,
@(x)SourbronM_Ke_ODE_func(x,time_data,signal_data,name,emb),
’x0’,x0,’Aineq’,A,’bineq’,b,’lb’,lb,’ub’,ub,’options’,opts);
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ms = MultiStart(’UseParallel’,’always’);
[x RMS] = run(ms,problem,4000);
for n = 1:length(t)-1
Cs(n+1) = (Finput/vs)*((1-fa)*pvif_corr(n)+
fa*aif_corr(n))*dt-Cs(n)*((Ki+Finput)/vs)*dt+Cs(n);
Ch(n+1) = (Ki/vh)*Cs(n)*dt-(Ke/vh)*Ch(n)*dt+Ch(n);
end
Cs = vs*Cs;
Ch = vh*Ch;
Ct = Cs+Ch;
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Table B.1: 2CUM[600] Fixed volume
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 81.6 27 16 16 74 74
Quantile 25 47.8 11.1 16 16 74 74
Quantile 75 138.9 43 16 16 74 74
Mean 158.6 30 16 16 74 74
Standard deviation 198.6 20.5 0 0 0 0
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 10.4 3.5 0 0 21.4 100
Quantile 25 6 1.4 0 0 1 100
Quantile 75 11.1 4.7 0 0 50 100
Mean 9.4 3.2 0 0 24.8 100
Standard deviation 3.5 2.1 0 0 23.6 0
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Table B.2: 2CUM[600] Fitted volume LB
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 80.3 25.1 16.8 16.8 73.3 73.6
Quantile 25 45.4 17.4 16.8 15.8 72 72.4
Quantile 75 129.8 41.9 16.8 16.8 76.4 75.7
Mean 141 30.5 16.7 16.4 73.9 74
Standard deviation 162.9 19.1 0.5 0.7 2.5 2.1
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 10.3 3 0 0 23.9 100
Quantile 25 6.1 1.8 0 0 1 100
Quantile 75 11 3.7 0 0 50 100
Mean 9.4 2.9 0 0 25.2 100
Standard deviation 3.4 1.6 0 0 23.6 0
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Table B.3: 2CUM[600] Fitted volume HB
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 62.8 20.6 31 20.7 61.9 65.3
Quantile 25 39.3 13.1 27 16.8 60 61
Quantile 75 90.6 40.9 35 26.2 64.3 68.5
Mean 65.5 26.2 29.5 22 63.1 65.3
Standard deviation 32.1 15.7 6.3 6.9 4.6 4.4
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 7.6 2.2 0 0 18 100
Quantile 25 6 1 0 0 5.7 100
Quantile 75 9.3 2.7 0 0 39.4 100
Mean 7.9 1.9 0 0 22 100
Standard deviation 3.4 1.2 0 0 19.4 0
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Table B.4: 2CUM[AD] Fixed volume
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 49 26.1 16 16 74 74
Quantile 25 27.3 17.1 16 16 74 74
Quantile 75 85 43.1 16 16 74 74
Mean 54.4 31.5 16 16 74 74
Standard deviation 30.2 23.7 0 0 0 0
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 6.1 2.6 0 0 50 100
Quantile 25 5.2 2 0 0 50 100
Quantile 75 7.2 3.2 0 0 50 100
Mean 6.4 3.2 0 0 48.1 100
Standard deviation 2.1 3.2 0 0 4.7 0
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Table B.5: 2CUM[AD] Fitted volume LB
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 46 26.4 16.8 16.8 74.1 72
Quantile 25 25.8 14.7 16.8 15.2 71.9 70.9
Quantile 75 83.7 41.7 16.8 16.8 76.5 74
Mean 53.1 31.6 16.8 16.2 74.2 72.3
Standard deviation 29.9 21.6 0 0.8 2.4 1.6
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 6.2 2.5 0 0 50 100
Quantile 25 5.2 1.7 0 0 50 100
Quantile 75 7.2 2.9 0 0 50 100
Mean 6.4 2.4 0 0 48.4 100
Standard deviation 2.1 0.8 0 0 3.8 0
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Table B.6: 2CUM[AD] Fitted volume HB
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 34.4 19.8 35 19.6 60 63.4
Quantile 25 23 13.4 29.6 15.1 60 61.9
Quantile 75 57.7 40.4 35 27 61.9 68.7
Mean 38.2 26.3 32.7 20.7 61.4 65.9
Standard deviation 19.4 15.6 3.6 6.9 2.7 6.1
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 5.9 2.3 0 0 50 100
Quantile 25 4.9 1.5 0 0 49 100
Quantile 75 7.3 2.7 0 0 50 100
Mean 6 2.2 0 0 46.8 100
Standard deviation 2.3 0.8 0 0 8.6 0
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Table B.7: 2CUMEX[AD] Fixed volume
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 148.2 28 16 16 74 74
Quantile 25 59.3 15.9 16 16 74 74
Quantile 75 346.4 41 16 16 74 74
Mean 337.2 30 16 16 74 74
Standard deviation 494.2 20.2 0 0 0 0
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 12.1 3.7 5 0.9 1 100
Quantile 25 7.3 2.2 2.6 0.1 1 100
Quantile 75 15.3 5.2 8.2 3.8 9.6 100
Mean 12.1 4.9 5.5 1.9 9.5 100
Standard deviation 5.2 5.3 3.4 2.1 16 0
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Table B.8: 2CUMEX[AD] Fitted volume LB
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 128.6 23 16.8 16.8 74.7 75.5
Quantile 25 60.8 15.4 16.8 15.3 73.2 72.7
Quantile 75 313.7 41.7 16.8 16.8 76.3 77.2
Mean 319.2 29.8 16.5 16.2 74.6 75
Standard deviation 511.4 20.3 0.6 0.8 2.2 2.3
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 12 2.9 4.8 0.3 1.6 100
Quantile 25 7.1 2.1 2.4 0.1 1 100
Quantile 75 15.2 3.8 8.2 2.6 11 100
Mean 11.9 3 5.5 1.2 9.7 100
Standard deviation 5.1 1.3 3.5 1.5 15.3 0
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Table B.9: 2CUMEX[AD] Fitted volume HB
F [ml/min/100ml] vs[%] vh[%]
NEmb Emb NEmb Emb NEmb Emb
Median 71.6 20.5 28.8 19.5 62.8 73.7
Quantile 25 42.1 13.3 22.9 14.9 60 66.4
Quantile 75 86.5 42.1 35 25.3 65.7 80
Mean 69.7 26.7 28 20 63.7 73.4
Standard deviation 32.3 15.9 6.9 6.3 3.9 6.9
Ki[ml/min/100ml] Ke[ml/min/100ml] fa[%]
NEmb Emb NEmb Emb NEmb Emb
Median 9 2.4 2.3 0.1 14.3 100
Quantile 25 6.7 1.6 1.6 0.1 2.5 100
Quantile 75 11.2 3 3.9 0.1 40 100
Mean 9.4 2.4 2.7 0.2 20.6 100
Standard deviation 3.9 0.9 1.6 0.4 19.7 0
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